(MedPage Today) — Patients with limited metastatic/progressive cancers had good rates of local control and favorable survival with stereotactic body radiotherapy (SBRT) and no systemic therapy, according to a multicenter retrospective study from…
Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/117929
Author :
Publish date : 2025-10-13 21:25:00
Copyright for syndicated content belongs to the linked Source.
